Orgenesis Inc.
ORGS
$2.27
-$0.0525-2.26%
OTC PK
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/13/2024
-
Globe Newswire
10/21/2024
-
The Fly
10/21/2024
-
Globe Newswire
10/11/2024
-
MarketBeat - AP News
9/24/2024
-
The Fly
9/24/2024
-
Ticker Report
9/23/2024
-
Ticker Report
9/23/2024
-
Benzinga
9/23/2024
-
TipRanks Financial Blog
9/23/2024
-
The Fly
9/23/2024
-
Globe Newswire
9/21/2024
-
Ticker Report
9/1/2024
-
Zolmax
8/29/2024
-
The Fly
8/29/2024
-
Globe Newswire
8/14/2024
-
The Fly
8/14/2024
-
Globe Newswire
8/9/2024
-
InvestorPlace
8/8/2024
-
The Fly
8/8/2024
-
Globe Newswire
7/12/2024
-
The Fly
7/9/2024
-
TipRanks Financial Blog
6/27/2024
-
TipRanks Financial Blog
6/17/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 14 and 18 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
480 659 6404
Address
20271 Goldenrod Lane
Germantown, MD 20876
Germantown, MD 20876
Country
Year Founded
Business Description
Sector
Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform...
more